Interpace Diagnostics Reports Third Quarter 2018 Financial Results, Business Progress and Recent Accomplishments

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. PRIM
2. ABBV
3. IBM
4. META
5. DPZ
6. DFTX
7. CNC
8. KFY
9. SPY
10. MU

Go back to Interpace Diagnostics Reports Third Quarter 2018 Financial Results, Business Progress and Recent Accomplishments

Interpace Diagnostics (IDXG) Reports Q3 Loss of $0.11, Revenues Beat

November 13, 2018 4:19 PM EST

Interpace Diagnostics (NASDAQ: IDXG) reported Q3 EPS of ($0.11), versus $0.00 reported last year. Revenue for the quarter came in at $5.8 million versus the consensus estimate of $5.57 million.

Expanded Guidance of Revenues for the Year to a Range between $21 and $22 MillionRevenue Grew to $5.8 Million in the Third Quarter 2018 or 37% over the Third... More